Heike Lentfer

Heike Lentfer is a seasoned professional in the biopharmaceutical industry with extensive experience in drug substance management and technology transfer. Currently serving as Senior Manager Drug Substance at MoonLake Immunotherapeutics since June 2024, Heike previously held the position of Head of MS&T at Akamis Bio from March 2021 to June 2024, where responsibilities included establishing the MS&T function and supporting biosimilar projects. Prior roles include Head of Biotherapeutics Development Unit at Cancer Research UK, overseeing process development and GMP manufacturing for early-phase clinical trials, and Head of Technology Transfer at Cobra Biomanufacturing. Earlier in the career, Heike held various roles focusing on mammalian cell culture and project management, starting as a Scientist at Alpha Bioverfahrenstechnik. Heike holds a Dipl.-Ing. in Biotechnology from Technische Universität Berlin.